An Open‐Label Study of the Safety and Efficacy of Tag‐7 Gene‐Modified Tumor Cells‐Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer

LESSONS LEARNED: This study showed that carefully selected patients with locally advanced and metastatic forms of malignant melanoma and renal cell carcinoma could potentially have long‐term disease control with a tag‐7 gene‐modified tumor cells‐based vaccine. Randomized clinical trials in patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Novik, Aleksei Viktorovich, Danilova, Anna Borisovna, Sluzhev, Maksim Ivanovich, Nehaeva, Tatiana Leonidovna, Larin, Sergei Sergeevich, Girdyuk, Dmitry Viktorovich, Protsenko, Svetlana Anatolevna, Semenova, Anna Igorevna, Danilov, Aleksei Olegovich, Moiseyenko, Vladimir Mikhailovich, Georgiev, Georgii Pavlovich, Baldueva, Irina Aleksandrovna
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Trial Results
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485366/
https://ncbi.nlm.nih.gov/pubmed/32240562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0160
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares